PLx Pharma Inc.

PLXP · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$46-$15-$21$1
Dep. & Amort.$0$0$0$0
Deferred Tax$5$2$6$0
Stock-Based Comp.$3$1$1$0
Change in WC$5-$0$1$0
Other Non-Cash$0$0$0-$12
Operating Cash Flow-$32-$12-$13-$9
Investing Activities
PP&E Inv.$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0-$0-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$74$17$2$0
Stock Repurch.$8$2$14$0
Dividends Paid$0$0$0$0
Other Fin. Act.$79$21$13$0
Financing Cash Flow$79$21$13$0
Forex Effect$0$0$0$0
Net Chg. in Cash$47$8-$0-$10
Supplemental Information
Beg. Cash$22$14$14$24
End Cash$69$22$14$14
Free Cash Flow-$32-$12-$13-$10
PLx Pharma Inc. (PLXP) Financial Statements & Key Stats | AlphaPilot